Replies to post #99354 on Biotech Values

[DewDiligence]

NVS has annual sales of almost $50B (#msg-52296278). Even a product as consequential as generic Lovenox will not move the needle that much for them.

[alertmeipp]

Lovenox sales is about about 2.5B.
NVS's revenue is about 50B.

so 5%....not significant for them.

MNTA's market cap is about 500M... just give you an idea..